2008
DOI: 10.1016/j.hoc.2007.10.003
|View full text |Cite
|
Sign up to set email alerts
|

Antiphospholipid Antibody Syndrome and Autoimmune Diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
9
0

Year Published

2008
2008
2021
2021

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 25 publications
(10 citation statements)
references
References 52 publications
1
9
0
Order By: Relevance
“…Likewise, the ESR, disease activity score, and SSc subset were not found to predict coronary calcification. Antiphospholipid antibodies were present in 13.2% of the SSc patients in this study and were not particularly associated with coronary atherosclerosis, consistent with the results of a previous study (38). Other previously identified predisposing factors to atherosclerosis, including lipoprotein(a) and anti-oxidized LDL antibodies (34,39), are worth examining in future studies.…”
Section: Discussionsupporting
confidence: 91%
“…Likewise, the ESR, disease activity score, and SSc subset were not found to predict coronary calcification. Antiphospholipid antibodies were present in 13.2% of the SSc patients in this study and were not particularly associated with coronary atherosclerosis, consistent with the results of a previous study (38). Other previously identified predisposing factors to atherosclerosis, including lipoprotein(a) and anti-oxidized LDL antibodies (34,39), are worth examining in future studies.…”
Section: Discussionsupporting
confidence: 91%
“…Immunologic conditions less frequently associated with aPL are lupus-like syndrome, Sjögren’s syndrome, rheumatoid arthritis, scleroderma, and systemic vasculitis (Ostrowski and Robinson, 2008). …”
Section: Introductionmentioning
confidence: 99%
“…2) MHC protein complexes were identified and are presumably involved in the presentation of autoantigens [16]. 3) The finding that protein-lipid complexes and lipoprotein particles are associated with Sjögren's syndrome may be consistent with changes in serum lipid levels in Sjögren's syndrome patients [35] although the prevalence of anti-phospholipid antibodies is low in Sjögren's syndrome [36]. 4) Nerve terminals and axons were also prominent cellular components, consistent with the known neurological component of Sjögren's syndrome [37].…”
Section: Utility and Discussionmentioning
confidence: 99%